We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avingtrans Plc | LSE:AVG | London | Ordinary Share | GB0009188797 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 387.50 | 380.00 | 395.00 | 387.50 | 387.50 | 387.50 | 29,510 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Engineering Services | 136.62M | 3.65M | 0.1108 | 34.97 | 127.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/7/2023 14:31 | Opportunistic - if completed they'll get 80% of Adaptix for less than they paid for 11.9% initially.Clearly the rails have come off at Adaptix with regard to external funding and they've recently lost the Co-founder and CEO. Classic AVG distressed play. | cockerhoop | |
13/7/2023 12:54 | A rather interesting development, because at the AGM I attended two years ago, AVG stated that having taken a small holding in Adaptix on reflection it would have been better to go for a total buyout but they were too far down the road that now. Secondly it was stated that Adaptix were, ultimately looking to list on NASDAQ, I wonder why the change???? | dgwinterbottom | |
13/7/2023 07:50 | I note revenue up from last year's £100.4m and adjusted Ebitda this year also from last year's £12.7m also up with net cash down. I plan to remain with what I have but not expecting any real movement in the share price over the rest of 2023. Good for them to specify their understanding of market expectations. | cerrito | |
13/7/2023 06:29 | Another confident & 'in line' trading update from specialist engineer Avingtrans today - alongside a possible nice piece of M&A too. All the details here. | brummy_git | |
13/7/2023 06:29 | Solid set of results within difficult trading climate with record order book. Mopping up the rest of Adaptix which has serious potential to add value to the company. Well done, very happy with this. Surprised it is so quiet here. Another great stock under the radar and part of the Harwood folio. | earwacks | |
19/6/2023 10:29 | Quietly drifting up for a change. Little leaky squeak somewhere? Should be a good bit of news hopefully | earwacks | |
16/6/2023 14:54 | Bit more action today. Chris Mills of Harwood Capital have discussed prospects on AVG a couple of times. Break up value £5 but medical diagnostics potential £8 plus. Gl | earwacks | |
28/3/2023 07:12 | ...in France | rogerrail | |
27/3/2023 12:05 | EQT could be a great fit for AVG at its current lowly valuation of less than £19m . They are making good traction | rogerrail | |
23/2/2023 18:43 | Cerrito - why not email Stephen King and ask the question he is very approachable having met him many times. sking@avingtrans.plc | dgwinterbottom | |
22/2/2023 15:00 | Paul Scott in his report was right to flag receivables figure which equates to more than 6 months revenue. Not clear to me why they classified receivables in excess of a year as current. If there had been an IMC session I hope I would have organized myself to ask about this. Good to see cash flow from operations healthy and share based compensation expenses modest at £118k in the half. I found their comments in the podcast that the Oil Windfall tax had encouraged investment as counter intuitive after the announcements from HBR and ENQ cancelling projects and I will be interested to see if other suppliers there have the experience of Avg. Today's share price weakness may reflect that eps this half year was 7.8p compared to 9 and 9.8p on H1 and H2 last year. I plan to go back to sleep on Avg. | cerrito | |
22/2/2023 09:07 | Yes thanks for the link from me as well | cerrito | |
22/2/2023 08:59 | Appreciated Paul, added some decent detail above today's statement. | cockerhoop | |
22/2/2023 07:45 | In this fascinating interview, CEO Steve McQuillan & CFO Stephen King, take me through Avingtrans' in line H1'23 results & positive FY'23 outlook. | brummy_git | |
22/2/2023 07:35 | Yes good solid results. I see Finn do not change forecasts and have a 495 tp. Note slow progress on Luton and let us hope house builders feel comfortable buying land again soon. Interested to note their comment that after sales service the Achilles heel of engineering companies. Too bad they have no IMC type event but I thought the report gave a very clear insight into what is going on. Note that the Chairman did all the writing and the CEO did not get a look on | cerrito | |
22/2/2023 07:16 | Strong H1'23 numbers today, alongside an 'in line' outlook from niche products & services engineer Avingtrans. All the details here. | brummy_git | |
16/2/2023 21:28 | I understand we are having the interims next Wednesday | cerrito | |
30/1/2023 07:19 | More good news from niche engineer Avingtrans today - saying that its associate Adaptix Imaging (11.9% stake) had secured US FDA approval for its new 3D small-form X-ray machine. All the details here. | brummy_git | |
18/1/2023 08:01 | Can't make up my mind if this was forced on them to keep Magnetically afloat. Perhaps I misread it earlier but had impression that no one else would fund? | ayl30 | |
18/1/2023 07:58 | Another positive follow on investment (£6m) by Avingtrans to lift its stake in disruptive, medical devices firm Magnetica from 61% to 74%. All the details here. www.linkedin.com/pos | brummy_git | |
16/1/2023 09:09 | Should be a further RNS this week regards AVG's Magnetica stake post GM overnight tonight in Brisbane. | cockerhoop | |
16/1/2023 07:08 | More positive trading and M&A news from specialist engineer Avingtrans today. All the details here. www.linkedin.com/pos | brummy_git |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions